Study identifies potential drug targets for muscular dystrophy treatments
Myotonic dystrophy type I (MD1) is a common form of muscular dystrophy associated with muscle wasting, weakness, and myotonia. These symptoms are linked to the accumulation of toxic gene transcripts in muscle cells that result ...
Jan 9, 2017
0
0